Дмитренко, І. В. (2018). Prognostic value of early reduction of BCR/ABL1 gene expression in criteria of deep molecular response on imatynib therapy in patients with chronic myeloid leukemia. Problems of Environmental Biotechnology, (1). https://doi.org/10.18372/2306-6407.1.12851